Galt Associates (Sterling, VA) has brought together the original Halo web-based safety research and monitoring environment with its dsNavigator search engine for a new and improved Halo platform. Featuring streamlined yet powerful querying capabilities, the platform offers ready access to a vast array of information sources-including FDA and WHO datasets-while a sophisticated interface gives safety professionals automated tools and an intuitive way to manage and analyze data.
Galt Associates (Sterling, VA) has brought together the original Halo web-based safety research and monitoring environment with its dsNavigator search engine for a new and improved Halo platform. Featuring streamlined yet powerful querying capabilities, the platform offers ready access to a vast array of information sources—including FDA and WHO datasets—while a sophisticated interface gives safety professionals automated tools and an intuitive way to manage and analyze data.
Haloâ¢
By using both data mining and traditional signaling methods, the new Halo allows researchers to thoroughly profile drugs and signal unexpected events proactively. Users define their own optimal search variables and can manipulate multiple output panels in real time. The graphical interface translates data from multiple internal and external sources into one common format, allowing for easier, more seamless investigation. An open platform and modular architecture allow users to customize extensions.
With Halo, Galt has created an integrated "intelligence" center that supports the safety monitoring and analysis needs of any company.
Galt Associates, (703) 547-3388, www.DrugSafety.com
ClinPhone (Princeton, NJ) has polished up the TrialWorks clinical trial management software (CTMS) it purchased from TrialTrac in 2004. TrialWorks now offers two-way integration with IVR/IWR in version 4.4.
TrialWorks⢠4.4
Let's say a user has just entered a subject visit into ClinPhone's interactive voice or Web response services. Previously, that information had to be entered again into the separate TrialWorks CTMS system in order for both systems to be fully updated. But now one system can instant-message the other and—zip!—the transaction is updated on the receiving end.
Users can also send site certification or qualification data, blast out study alerts, generate lots of new reports, and utilize expanded mail merge options.
Of course, TrialWorks still offers all the excellent database management features of previous editions. The system is 21 CFR 11 compliant. With version 4.4 it has become more user-friendly, intuitive and flexible, and it's done so by discussing workflow and practical needs directly with their clients.
In most cases, TrialWorks can be implemented in just two days.
ClinPhone, (609) 524-4100, www.clinphone.com or www.clinicaltrialsoftware.com
Medidata Solutions (New York, NY) has overcome one of the biggest obstacles in e-clinical trials: ensuring users can adopt new technologies. Their newest release—Rave 5.4—is a data capture and management software package that's easy to use and deploy, and allows for local lab data integration and more efficient system administration. It also lets users work off-line for even higher site adoption and increased efficiency.
Medidata Rave 5.4
Because it provides early visibility into critical data, user-friendly Rave also helps drive better decision making and lower overall risk for trial sponsors. With cost and pipeline pressures on the rise, the speedy delivery of innovations to market and the need for greater value for cost become critical factors. Rave addresses those needs by automating, streamlining and accelerating the flow of information. Among its enhancements are multiple subject views in real time, enhanced report administration, integrated dictionary coding, and translation tools.
Companies looking to improve their efficiencies and lower costs should find Rave's improved functionality appealing.
Medidata Solutions, (212) 918-1800, www.medidatasolutions.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
New Data Emerges from Phase IIb RELIEVE UCCD Study in Ulcerative Colitis and Crohn’s Disease
February 25th 2025Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) achieved higher rates of clinical remission compared to placebo in the advanced therapy-experienced subgroup.